|
|
The issue of determining antidepressants
Kočnar, Michal ; Tulková, Tereza (referee) ; Vávrová, Milada (advisor)
The presented bachelor thesis is focused on the issue of antidepressants and the determination of two of their representatives, paroxetine and citalopram, in sewage taken from three municipal waste water treatment plants. In the theoretical part of this study, antidepressants are generally characterized, more specifically two representatives of selective serotonin reuptake inhibitors, paroxetine and citalopram. Subsequently, the methods of determination of these analytes in waste water are presented. The experimental part deals with determination of selected substances in real samples of waste water. The analytes were isolated from the matrix by solid phase extraction and determined by ultra performance liquid chromatography with ultraviolet spectrophotometric detection. Paroxetine was quantified in all samples, citalopram was not able to quantify, in some samples even to detect.
|
|
|
Optimization and validation of analytical method for determination of selected drugs
Geryk, Radim ; Tesařová, Eva (advisor) ; Janečková, Lucie (referee)
The aim of this work was finding suitable conditions for separation of enantiomers of citalopram and citadiol, optimization of chromatographic system and validation of the analytical method for determination of selected enantiomers in drugs. Drugs are often chiral compounds. In many cases, only enantiomer has required pharmacological effects. Advanced chemical technologies associated with the synthesis, separation and analysis of the individual enantiomers caused an increase of the number of new chiral drugs in the form of single pure enantiomers, the chiral switch. Citalopram is one of the widely used antidepressants of selective serotonin reuptake inhibitors (SSRI). Citalopram is used for treatment of depression, panic anxienty or obsessive compulsive disorder of pathological laughing and crying. The pharmacological activity is associated with the S-citalopram, while R-enantiomer is essentially inactive and even counteracts the activity of escitalopram. Citadiol is a chiral syntetic precursor of citalopram. This thesis was focused on monitoring enantioseparation "behaviour" of selected enantiomers. HPLC method with chiral stationary phases based on macrocyclic antibiotics, cyclofructans and cellulose was applied for enantioseparation of the above-mentioned compounds. The optimized chromatographic...
|
|
|
Determination of enantiomers of selected drugs by HPLC
Geryk, Radim ; Tesařová, Eva (advisor) ; Chudoba, Richard (referee)
Drugs are often chiral compounds. In many cases only one of the enantiomers has required therapeutical effects. Citalopram belongs to a group of chiral drugs. This drug is used as an antidepresivum for treating anxiety, fear or suppressing of pain feeling. Its synthetical precursor is named citadiol and this compound is also chiral. HPLC method with chiral stationary phases based on macrocyclic antibiotics was applied for enantioseparation of above-mentioned compounds. Polar-organic and ionic-polar separation modes were found to be suitable for chiral separation of citalopram and citadiol enantiomers. The aim of this work was monitoring of enantioseparation "behaviour" of selected enantiomers and to find suitable separations conditions using HPLC method.
|
|
|
Anti-platelet effects of citalopram
Richter, Tomáš ; Alušík, Štefan (advisor) ; Jirák, Roman (referee) ; Matějovská Kubešová, Hana (referee)
Introduction Citalopram is a preferred medication used for the treatment of depression and belongs to a group known as selective serotonin reuptake inhibitors (SSRI). When used on a long-term basis, it leads to a significant decrease of serotonin in thrombocytes. Citalopram-treated patients often display haemorrhagia that is explained by its anti-platelet effect, which is also - more or less - the case for other medications from the SSRI group. Aim of the Thesis The aim of the thesis was to find out: a) Whether citalopram treatment (2 weeks) has influence on the plasma concentration of thromboxane B2; b) Whether there is a relation between the expected decrease of thromboxane B2 levels and the plasma concentration of citalopram. Methods and Patient Population We carried out clinical and laboratory tests on a study population consisting of elderly and polymorbid patients who underwent a 14-day citalopram treatment with daily doses of 20mg. Among other tests, we observed the plasma concentration of thromboxane and citalopram. Out of 160 patients examined, 78 patients were assessed. Results Our study has proved that even a short-term citalopram treatment results to a significant increase in the plasma concentration of thromboxane B2 and the suppression rate of thromboxane B2 correlates with the higher...
|
|
|
Anti-platelet effects of citalopram
Richter, Tomáš ; Alušík, Štefan (advisor) ; Jirák, Roman (referee) ; Matějovská Kubešová, Hana (referee)
Introduction Citalopram is a preferred medication used for the treatment of depression and belongs to a group known as selective serotonin reuptake inhibitors (SSRI). When used on a long-term basis, it leads to a significant decrease of serotonin in thrombocytes. Citalopram-treated patients often display haemorrhagia that is explained by its anti-platelet effect, which is also - more or less - the case for other medications from the SSRI group. Aim of the Thesis The aim of the thesis was to find out: a) Whether citalopram treatment (2 weeks) has influence on the plasma concentration of thromboxane B2; b) Whether there is a relation between the expected decrease of thromboxane B2 levels and the plasma concentration of citalopram. Methods and Patient Population We carried out clinical and laboratory tests on a study population consisting of elderly and polymorbid patients who underwent a 14-day citalopram treatment with daily doses of 20mg. Among other tests, we observed the plasma concentration of thromboxane and citalopram. Out of 160 patients examined, 78 patients were assessed. Results Our study has proved that even a short-term citalopram treatment results to a significant increase in the plasma concentration of thromboxane B2 and the suppression rate of thromboxane B2 correlates with the higher...
|
|
|
The issue of determining antidepressants
Kočnar, Michal ; Tulková, Tereza (referee) ; Vávrová, Milada (advisor)
The presented bachelor thesis is focused on the issue of antidepressants and the determination of two of their representatives, paroxetine and citalopram, in sewage taken from three municipal waste water treatment plants. In the theoretical part of this study, antidepressants are generally characterized, more specifically two representatives of selective serotonin reuptake inhibitors, paroxetine and citalopram. Subsequently, the methods of determination of these analytes in waste water are presented. The experimental part deals with determination of selected substances in real samples of waste water. The analytes were isolated from the matrix by solid phase extraction and determined by ultra performance liquid chromatography with ultraviolet spectrophotometric detection. Paroxetine was quantified in all samples, citalopram was not able to quantify, in some samples even to detect.
|
|
|
Optimization and validation of analytical method for determination of selected drugs
Geryk, Radim ; Tesařová, Eva (advisor) ; Janečková, Lucie (referee)
The aim of this work was finding suitable conditions for separation of enantiomers of citalopram and citadiol, optimization of chromatographic system and validation of the analytical method for determination of selected enantiomers in drugs. Drugs are often chiral compounds. In many cases, only enantiomer has required pharmacological effects. Advanced chemical technologies associated with the synthesis, separation and analysis of the individual enantiomers caused an increase of the number of new chiral drugs in the form of single pure enantiomers, the chiral switch. Citalopram is one of the widely used antidepressants of selective serotonin reuptake inhibitors (SSRI). Citalopram is used for treatment of depression, panic anxienty or obsessive compulsive disorder of pathological laughing and crying. The pharmacological activity is associated with the S-citalopram, while R-enantiomer is essentially inactive and even counteracts the activity of escitalopram. Citadiol is a chiral syntetic precursor of citalopram. This thesis was focused on monitoring enantioseparation "behaviour" of selected enantiomers. HPLC method with chiral stationary phases based on macrocyclic antibiotics, cyclofructans and cellulose was applied for enantioseparation of the above-mentioned compounds. The optimized chromatographic...
|
|
|
Determination of enantiomers of selected drugs by HPLC
Geryk, Radim ; Chudoba, Richard (referee) ; Tesařová, Eva (advisor)
Drugs are often chiral compounds. In many cases only one of the enantiomers has required therapeutical effects. Citalopram belongs to a group of chiral drugs. This drug is used as an antidepresivum for treating anxiety, fear or suppressing of pain feeling. Its synthetical precursor is named citadiol and this compound is also chiral. HPLC method with chiral stationary phases based on macrocyclic antibiotics was applied for enantioseparation of above-mentioned compounds. Polar-organic and ionic-polar separation modes were found to be suitable for chiral separation of citalopram and citadiol enantiomers. The aim of this work was monitoring of enantioseparation "behaviour" of selected enantiomers and to find suitable separations conditions using HPLC method.
|
|
| |
|
| |
guest ::
